#NYValves2026
LightNews LightNews
medpagetoday.com
The persistent peridevice leaks in percutaneous left atrial appendage closure may be addressed by applying pulsed field ablation during the procedure, the STUN-AF study suggested. @crfheart.bsky.social #NYValves2026
https://www.medpagetoday.com/meetingcoverage/nyv/121962
Pulsed Field Ablation Tied to Fewer LAA Occluder Leaks
Operators come to grips with LAA contractility in observational study
www.medpagetoday.com
June 29, 2026 at 2:30 PM
tctmd.bsky.social
It's a wrap on #NYValves2026! Watch David Cohen and Sammy Elmariah discuss the late-breaking presentations from the final day of the conference. www.tctmd.com/videos/ny-va...
June 26, 2026 at 8:52 PM
crfheart.bsky.social
Your research deserves the spotlight! Submit your science to #NYValves2026 for a chance to take the stage where global leaders shape the future of structural heart care. 🌐🚀

Submit your work today! 👉 https://www.nyvalvesconference.com/topics-categories-guidelines

#CardioSky #MedSky
January 22, 2026 at 11:01 PM
jamacardiology.com
💬 Editorial: At 7 years, #TAVR and #SAVR showed similar rates of structural valve deterioration and failure for low-risk #AorticStenosis, with small annulus predicting higher risk. #NYValves2026 ja.ma/4wz2XtI
Toward a Lifetime Strategy for Aortic Valve Replacement—Ariadne’s Thread
The expansion of transcatheter aortic valve replacement (TAVR) into younger and lower-risk populations has fundamentally reshaped the central question in the management of aortic stenosis (AS).1-3 Procedural safety and early outcomes are no longer the dominant concerns. Instead, the focus has...
ja.ma
August 19, 2026 at 12:00 PM
crfheart.bsky.social
The LAAC Summit is where the world’s top minds meet to innovate, collaborate, and advance care. ✨

Meet the leadership team developing this year’s #LAACatNYValves program and join them in NYC! 👉 https://ow.ly/iPQp50YOJpV

#NYValves2026 #AFib #CardioSky #MedSky
April 25, 2026 at 7:00 PM
crfheart.bsky.social
🔥 Mitral valve innovation is back in a big way at #NYValves2026 🗽

Learn from experts like Dr. Karim Al-Azizi & build new skills through iCOACH & interactive training designed to elevate your approach to patient care.

 Explore the program guide & secure your spot today! https://ow.ly/1r1450Z5P9i
May 30, 2026 at 12:02 PM
crfheart.bsky.social
Mark your calendar for #NYValves2026 — where visionaries unite to shape the future of structural heart care!🗽

Get ready for dynamic discussions, live cases, and hands-on training.✨ Sign up for CRF notifications and stay ahead of the latest updates and openings! 📢 https://ow.ly/VcTj50Xqetn
November 11, 2025 at 10:05 PM
crfheart.bsky.social
Ready to reimagine what’s possible in structural and valvular heart disease? Now’s your chance to bring bold ideas to life! ✨

Submit your novel technologies to #NYValves2026 and help shape the future of patient care 🌎 Deadline: April 21 | 2:00 PM EDT (UTC −4) 👉 https://ow.ly/Zzn350YK3NC #CardioSky
April 19, 2026 at 3:01 PM
crfheart.bsky.social
📢 Calling all clinical cardiologists! Join us in NYC and ✨SAVE✨ with exclusive rates at #NYValves2026

Where the #HeartTeam comes together to:
💡 Discover breakthrough science
🔎 Elevate imaging expertise
🏥 Build skills with hands-on training

👉 https://ow.ly/qvEq50Zc6Jy

#CardioSky #MedSky
June 18, 2026 at 2:02 PM
crfheart.bsky.social
💥 The final countdown to #NYValves2026 is here — and it all starts with an unforgettable Opening Session!

Dive into the evolution of structural heart care and celebrate Dr. Igor Palacios, recipient of the Career Achievement Award, whose legacy continues to inspire. 🫀🗽

🔗 https://ow.ly/BFbj50Zc6sq
June 17, 2026 at 3:01 PM
medpagetoday.com
A TAVR system could work as a last resort for patients with LVAD-associated aortic regurgitation, according to a retrospective study. @crfheart.bsky.social #NYValves2026
https://www.medpagetoday.com/meetingcoverage/nyv/121973
JenaValve TAVR Device Promising for LVAD-Associated Aortic Regurgitation
Good results reported with emergency-use and compassionate-use cases
www.medpagetoday.com
June 29, 2026 at 9:08 PM
medpagetoday.com
People with aortic stenosis were increasingly getting timelier diagnosis, though treatment delays persisted in a national care quality registry study. @crfheart.bsky.social #NYValves2026
https://www.medpagetoday.com/meetingcoverage/nyv/121959
Aortic Stenosis Patients Still Tripped Up by Diagnosis Issues on the Path to AVR
Results of care registry released with new TAVR national coverage determination on the horizon
www.medpagetoday.com
June 29, 2026 at 3:16 PM
medpagetoday.com
"We're desperate for data." -- Martin Leon, MD, of Columbia University Irving Medical Center, warning of a critical blind spot regarding the real-world performance of transcatheter aortic valve replacements. #NYValves2026 @crfheart.bsky.social
www.medpagetoday.com/meetingcover...
Midterm TAVR Data Turn Muddy: Will 10 Years Even Suffice for a Verdict?
Real-world mortality complicates reassurances in trial results
www.medpagetoday.com
June 29, 2026 at 1:48 PM
tctmd.bsky.social
New STUN-AF data suggest that ablating the left atrial appendage before LAAO during combined PFA-LAAO procedures may help reduce peridevice leaks in patients with AF or atrial flutter. #NYValves2026 www.tctmd.com/news/stun-af...
STUN-AF: Ablation Before LAAO May Reduce Peridevice Leaks
The approach should be considered to prevent leaks, which have been tied to increased stroke risks, Vivek Reddy says.
www.tctmd.com
July 11, 2026 at 1:03 PM
medpagetoday.com
Real-world operators have been leaving patients with acceptable but still less-than-optimal results after transcatheter mitral edge-to-edge repair, with some suggesting moving the goalposts for success. #NYValves2026 @crfheart.bsky.social
https://www.medpagetoday.com/meetingcoverage/nyv/121937
Is the Bar Too Low for Transcatheter Mitral Repair in Real-World Practice?
'In surgery ... we would all be horrified,' said one physician
www.medpagetoday.com
June 26, 2026 at 3:29 PM
jamacardiology.com
Small aortic annulus increased risk of structural valve degeneration and failure after #TAVR or #SAVR, supporting careful anatomical assessment in long-term management of #AorticStenosis. #NYValves2026 ja.ma/4wwYo2Y
Seven-Year Valve Durability With TAVR
This ad hoc analysis of a randomized clinical trial reports on the 7-year outcomes among a group of low-risk patients with symptomatic severe aortic stenosis treated with transcatheter aortic valve replacement vs surgery.
ja.ma
August 25, 2026 at 12:00 PM
tctmd.bsky.social
In the final installment of this three-part video discussion from #NYValves2026, experts share their perspectives on Centers for Medicare & Medicaid Services' consideration of changes to the NCD for TAVI and the future of the field. Watch now: www.tctmd.com/videos/ny-va...
July 29, 2026 at 7:09 PM
tctmd.bsky.social
In Part 2 of this three-part discussion from #NYValves2026 on Centers for Medicare & Medicaid Services consideration of changes to the NCD for TAVI, watch a panel of experts discuss the potential impact on patients and heart teams. www.tctmd.com/videos/ny-va...
July 22, 2026 at 3:58 PM
tctmd.bsky.social
At the recent #NYValves2026, watch Michael Mack and Roxana Mehran moderate a panel discussion on the Centers for Medicare & Medicaid Services' consideration of TAVI coverage for asymptomatic severe aortic stenosis. www.tctmd.com/videos/ny-va...
July 16, 2026 at 3:42 PM
tctmd.bsky.social
New data suggest that AI-enabled ECGs could help identify at-risk patients with structural heart disease and address underdiagnosis. However, further improvements in screening performance are needed. #NYValves2026 www.tctmd.com/news/ai-ecg-...
AI-ECG Models Detect Structural Heart Disease, Identify At-Risk Patients
The tools may help address underdiagnosis in this area, though there is still room for improvement in screening performance.
www.tctmd.com
July 15, 2026 at 3:09 PM
tctmd.bsky.social
New real-world data show LAMPOON outcomes for TMVR vary by valve status. Thirty-day mortality was acceptable after valve-in-valve and valve-in-ring procedures, but remained high after valve-in-MAC. #NYValves2026 www.tctmd.com/news/lampoon...
LAMPOON in TMVR: Glimpse Into Real-world Outcomes
Mortality at 30 days was deemed “acceptable” after valve-in-valve and valve-in-ring procedures, but “high” after valve-in-MAC.
www.tctmd.com
July 14, 2026 at 1:34 PM
tctmd.bsky.social
Compared with the contralateral femoral artery, use of the radial artery for secondary access during TAVI appears to reduce the risk of bleeding and vascular complications at the access site, according to data from the SAFER-TAVI trial. www.tctmd.com/news/safer-t... #NYValves2026
SAFER-TAVI: Radial Eases Secondary Access Site Problems
The findings should lead to changes in practice, David Cohen says, but as seen in the setting of PCI, “old habits die hard.”
www.tctmd.com
July 13, 2026 at 1:58 PM
jamacardiology.com
💬 Editorial: At 7 years, #TAVR and #SAVR showed similar rates of structural valve deterioration and failure for low-risk #AorticStenosis, with small annulus predicting higher risk.

#NYValves2026
A JAMA Cardiology editorial: 'Toward a Lifetime Strategy for Aortic Valve Replacement—Ariadne's Thread' by Patrizio Lancellotti, Yun Yun Go, and Mani A. Vannan. Published Online: June 24, 2026. DOI: 10.1001/jamacardio.2026.0681.
June 24, 2026 at 2:40 PM
jamacardiology.com
Small aortic annulus increased risk of structural valve degeneration and failure after #TAVR or #SAVR, supporting careful anatomical assessment in long-term management of #AorticStenosis.

#NYValves2026
June 24, 2026 at 2:39 PM
myjscai.bsky.social
🗣️📣 New research presented at #NYValves2026 & published today in #JSCAI reported favorable 1year outcomes in patients with symptomatic severe #aorticregurgitation following treatment with the investigational J-Valve Transfemoral System. Read more💡

🔗 www.jscai.org/article/S277...
Transcatheter Aortic Valve Replacement in Patients with Symptomatic, Severe Aortic Regurgitation: 1-Year Outcomes of the J-Valve Transfemoral Early Feasibility Study
Clinically significant native aortic regurgitation (AR) increases with age. Surgical aortic valve replacement has been the only curative guideline-recommended therapy, while transcatheter options rema...
www.jscai.org
June 25, 2026 at 4:24 PM